Hot Picks: Pharma stocks gain on obesity drug demand - BNN Bloomberg

Pharmaceutical stocks are regaining momentum as investors grow more confident in obesity drugs, oncology treatments and innovation across the biotech sector. Analysts say improving earnings, renewed M&A activity and expanding treatment markets are helping support sentiment across healthcare names. BNN Bloomberg spoke with Evan Seigerman, managing director and head of healthcare research at BMO, about Eli Lilly, Gilead Sciences and Scholar Rock, and why he sees continued opportunities tied to metabolic disease, HIV prevention and rare disease therapies. Key Takeaways Investor sentiment toward…